The patient was implanted with the argus ii device on (b)(6) 2011.On (b)(6) 2013, the patient was diagnosed with hypotony, rubeosis iridis, corneal neovascularization, descemet folds and a slight tyndall.Ultrasound showed no choroidal detachment.Patient was prescribed medications.On (b)(6) 2013, the patient was diagnosed with a mild choroidal detachment and the medication were continued.The event continued and on (b)(6) 2013, the surgeon performed a revision surgery on the patient in which he re-sutured around the cable and applied a scleral patch over the sclerotomy.On (b)(6) 2014, the patient was seen for a follow-up visit and the hypotony was still unresolved.On (b)(6) 2014, the patient had a second revision surgery in which the surgeon injected silicone oil into his eye.On (b)(6) 2014, the patient had a follow-up visit and the hypotony is still present.The patient was prescribed eye drops (cortisone and trobadex).There was no defect of malfunction of the device associated with this event.
|